Related Experiment Video
Updated: May 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGF-β - an excellent servant but a bad master
Lenka Kubiczkova1, Lenka Sedlarikova, Roman Hajek
1Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, 625 00, Czech Republic.
Abstract:
The transforming growth factor (TGF-β) family of growth factors controls an immense number of cellular responses and figures prominently in development and homeostasis of most human tissues. Work over the past decades has revealed significant insight into the TGF-β signal transduction network, such as activation of serine/threonine receptors through ligand binding, activation of SMAD proteins through phosphorylation, regulation of target genes expression in association with DNA-binding partners and regulation of SMAD activity and degradation. Disruption of the TGF-β pathway has been implicated in many human diseases, including solid and hematopoietic tumors. As a potent inhibitor of cell proliferation, TGF-β acts as a tumor suppressor; however in tumor cells, TGF-β looses anti-proliferative response and become an oncogenic factor. This article reviews current understanding of TGF-β signaling and different mechanisms that lead to its impairment in various solid tumors and hematological malignancies.
Insights
Transforming growth factor-beta (TGF-β) signaling is crucial for tissue homeostasis but can become oncogenic when disrupted in cancer. This review details TGF-β pathway dysregulation in various human malignancies.
Area of Science:
- Cellular Biology
- Molecular Biology
- Oncology
Background:
- The transforming growth factor-beta (TGF-β) family regulates critical cellular processes including development and tissue homeostasis.
- Decades of research have elucidated key aspects of TGF-β signal transduction, involving receptor activation, SMAD protein phosphorylation, and gene expression regulation.
Purpose of the Study:
- To review the current understanding of TGF-β signaling pathways.
- To explore the mechanisms of TGF-β pathway impairment in solid tumors and hematological malignancies.
Main Methods:
- Literature review of TGF-β signaling mechanisms.
- Analysis of TGF-β pathway dysregulation in cancer.
Main Results:
- TGF-β acts as a tumor suppressor by inhibiting cell proliferation.
- In cancer cells, TGF-β signaling can be altered, leading to an oncogenic role.
- Dysregulation of the TGF-β pathway is implicated in numerous human diseases, including various cancers.
Conclusions:
- The TGF-β pathway is a complex network with a dual role in cancer, acting as both a tumor suppressor and an oncogenic factor depending on the cellular context.
- Understanding the mechanisms of TGF-β pathway impairment is vital for developing targeted cancer therapies.
Related Concept Videos
TGF - β Signaling Pathway
Master Transcription Regulators
Master Transcription Regulators
GTPases and their Regulation
Large G-proteins, also known...
GTPases and their Regulation
Large G-proteins, also known...
General Transcription Factors
